Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|January 14, 2005
No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitisM van der Paardt, J B A Crusius, M H M T de Koning, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Genes and Immunity|February 22, 2003
CARD15 gene mutations are not associated with ankylosing spondylitisM van der Paardt, J B A Crusius, M H M T de Koning, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritisM M J Nielen, D van Schaardenburg, H W Reesink, et al.
Annals of the Rheumatic Diseases|May 1, 2008
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritisW H Bos, G M Bartelds, M Vis, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort studyW H Bos, G J Wolbink, M Boers, et al.
Annals of the Rheumatic Diseases|February 23, 2007
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritisM J L Peters, M Vis, V P van Halm, et al.
Annals of the Rheumatic Diseases|April 5, 2008
The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levelsW H Bos, J Ursum, N de Vries, et al.
Annals of the Rheumatic Diseases|April 29, 2006
Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitisV P van Halm, J C van Denderen, M J L Peters, et al.
Arthritis and Rheumatism|May 1, 2009
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitisI C van Eijk, M K de Vries, J H M Levels, et al.
Pageof 5